Department of Respiratory Medicine, Portsmouth Hospitals University NHS Trust, Portsmouth, UK.
School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK.
Clin Respir J. 2024 Aug;18(8):e13811. doi: 10.1111/crj.13811.
COPD and bronchiectasis are common causes of morbidity, particularly around exacerbation. Colonisation with respiratory pathogens can increase the frequency and severity of exacerbations. However, bacterial and viral presence at exacerbation in people with airway colonisation has not been well studied.
A 6-month cohort study of participants (n = 30) with chronic bronchitis due to bronchiectasis (n = 26) and/or COPD (n = 13) and colonisation with Pseudomonas aeruginosa or Haemophilus influenzae was proven on two sputum cultures at exacerbation in the previous 12 months. Participants were provided self-management education and collected sputum samples daily. Sputum samples at baseline (at least 14 days before or after an exacerbation) and at each exacerbation were examined for a panel of 34 respiratory pathogens using commercially available RT-PCR kits and compared to results obtained using culture methods for the detection of bacteria.
Participants provided 29 baseline samples and 71 samples at exacerbation. In 17/29 baseline samples, RT-PCR analysis confirmed the organism demonstrated by culture, while 12 samples showed a discrepancy from culture results. Most exacerbations (57.7%) were not associated with acquiring new bacteria or viruses, while 19.8% showed new bacteria, 15.7% new viruses and 7% both new viruses and bacteria.
Over half of exacerbations were not associated with new organisms in this cohort of participants with chronic bronchitis and colonisation. However, 26.8% demonstrated a new bacterial species in sputum, which is relevant for antibiotic therapy. Baseline RT-PCR and culture results were discordant in one-third of participants.
COPD 和支气管扩张症是发病率较高的常见疾病,尤其是在病情加重时。呼吸道病原体定植可增加病情加重的频率和严重程度。然而,对于气道定植患者在病情加重时细菌和病毒的存在情况,尚未得到充分研究。
对 30 名患有支气管扩张症(n=26)和/或 COPD(n=13)且在过去 12 个月内两次痰培养证实存在铜绿假单胞菌或流感嗜血杆菌定植的慢性支气管炎患者进行了为期 6 个月的队列研究。参与者接受了自我管理教育,并每天收集痰样。在基线时(病情加重前至少 14 天或之后)和每次病情加重时,使用商业上可用的 RT-PCR 试剂盒检测了 34 种呼吸道病原体的检测板,并将结果与培养方法检测细菌的结果进行比较。
参与者提供了 29 份基线样本和 71 份病情加重时的样本。在 29 份基线样本中的 17 份中,RT-PCR 分析证实了培养物中显示的病原体,而 12 份样本与培养结果存在差异。大多数病情加重(57.7%)与未获得新细菌或病毒无关,而 19.8%显示有新细菌,15.7%有新病毒,7%同时有新病毒和细菌。
在这组患有慢性支气管炎和定植的患者中,超过一半的病情加重与新病原体无关。然而,26.8%的患者痰液中出现新的细菌种类,这与抗生素治疗相关。在三分之一的参与者中,基线 RT-PCR 和培养结果不一致。